BioGaia AB (publ) (LON:0GTN)
105.63
+0.23 (0.21%)
At close: Oct 21, 2025
BioGaia AB Revenue
BioGaia AB had revenue of 326.64M SEK in the quarter ending September 30, 2025, with 7.46% growth. This brings the company's revenue in the last twelve months to 1.46B, up 7.88% year-over-year. In the year 2024, BioGaia AB had annual revenue of 1.42B with 9.73% growth.
Revenue (ttm)
1.46B SEK
Revenue Growth
+7.88%
P/S Ratio
7.36
Revenue / Employee
6.50M SEK
Employees
225
Market Cap
849.51M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.42B | 126.21M | 9.73% |
Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 198.54B |
BP p.l.c. | 134.89B |
Unilever | 51.24B |
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Rio Tinto Group | 39.22B |
GSK plc | 31.63B |
British American Tobacco p.l.c. | 25.60B |